Skip to content

Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the All With Heart Association - Development of a Morocco-Specific Risk Score

Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the All With Heart Association - Development of a Morocco-Specific Risk Score

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07294937
Enrollment
10000
Registered
2025-12-19
Start date
2025-10-01
Completion date
2026-10-31
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases (CVD)

Brief summary

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and their prevalence is steadily increasing in Morocco. Between 2010 and 2012, the All with heart Association conducted a large-scale cardiovascular screening campaign in the Greater Casablanca region, involving more than 10,000 adults aged over 40 years. This 10-year follow-up study aims to evaluate long-term cardiovascular outcomes and to develop a Morocco-specific cardiovascular risk score. Follow-up data will be collected through phone calls, WhatsApp, or SMS with participants or their families to document cardiovascular deaths, myocardial infarctions, and strokes. Statistical analyses, including survival analysis and multivariate logistic regression, will be used to identify significant risk factors and to construct a predictive risk model tailored to the Moroccan population. The study received a favorable opinion from the Rabat Ethics Committee. Written informed consent will be obtained from all participants or their families prior to data collection. The findings are expected to enhance understanding of cardiovascular risk evolution in Morocco and to provide a validated, population-specific risk score to support prevention and patient management strategies.

Interventions

None listed

Sponsors

F&C Clinical Trials
CollaboratorUNKNOWN
Moroccan Society of Cardiology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 40 years or older at the time of the initial screening (2010-2012). * Individuals who participated in the cardiovascular risk screening campaign conducted by the All with heart Association between 2010 and 2012 in the Greater Casablanca region. * Moroccan nationality. * Participants or family members who provide written informed consent for participation in the 10-year follow-up study.

Exclusion criteria

* Individuals who refuse to participate in the follow-up study. * Participants who have moved and cannot be reached by phone, WhatsApp, or SMS. * Participants who died from non-cardiovascular causes. * Non-Moroccan participants.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Major Cardiovascular Events (MACE)10 years after initial screening (2010-2012)Occurrence of major cardiovascular events (myocardial infarction, stroke, or cardiovascular death) among participants screened for cardiovascular risk between 2010 and 2012 by the All with heart Association. Events will be identified during the 10-year follow-up period through participant or family contact (phone, WhatsApp, or SMS) and verified through available medical records when possible.
Development and Validation of a Morocco-Specific Cardiovascular Risk ScoreBaseline (2010-2012) and 10-year follow-up (2022)Development and internal validation of the Morocco-Specific Cardiovascular Risk Score, a composite risk prediction score estimating the 10-year probability of major cardiovascular events including myocardial infarction, stroke, or cardiovascular death. The score will be derived from baseline cardiovascular risk factors collected during the initial screening and weighted using multivariable regression models based on outcomes observed during the 10-year follow-up. The score will be expressed on a scale ranging from 0 to 100, where higher scores indicate a higher cardiovascular risk and therefore a worse outcome. Model performance will be assessed using discrimination and calibration measures, including the area under the receiver operating characteristic curve and calibration analyses.

Secondary

MeasureTime frameDescription
Incidence of Minor Cardiovascular Events10 years after initial screening (2010-2012)Occurrence of minor cardiovascular events, including stable or unstable angina, among participants screened between 2010 and 2012. Events will be collected through participant or family interviews and verified with medical records when available.

Other

MeasureTime frameDescription
Number of Hospitalizations Related to Cardiovascular Diseases10 years after initial screening (2010-2012)Total number of hospitalizations due to cardiovascular causes (acute coronary syndrome, heart failure, arrhythmia, or cardiac surgery) during the 10-year follow-up period.
Change in Cardiovascular Risk Factors Over Time10 years after initial screening (2010-2012)Change in major cardiovascular risk factors (body mass index, blood pressure, total cholesterol, triglycerides, HDL, blood glucose, smoking status, and physical activity) between the initial screening and the 10-year follow-up.
Quality of Life Assessment10 years after initial screening (2010-2012)Evaluation of participants' quality of life using a standardized questionnaire (EQ-5D). The assessment will explore mobility, self-care, usual activities, pain/discomfort, and anxiety/depression dimensions.

Countries

Morocco

Contacts

Primary ContactNajat MOUINE, Professor of Cardiology
mouine2@yahoo.fr+212661202733
Backup ContactMohamed ALAMI

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026